Plasma levels of platelet-derived microparticles in patients with obstructive sleep apnea syndrome

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 1, 2012, Pages 98-104

  Maruyama, Keiko ^a   Morishita, Eriko ^a   Sekiya, Akiko ^a   Omote, Mika ^b   Kadono, Tadaaki ^b   Asakura, Hidesaku ^a   Hashimoto, Masami ^c   Kobayashi, Masako ^c   Nakatsumi, Yasuto ^c   Takada, Shigeo ^c   Ohtake, Shigeki ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c Kanazawa Municipal Hospital   (Japan)

Author keywords

Apnea hypopnea index; Continuous positive airway pressure; Obstructive sleep apnea syndrome; Platelet derived microparticles

Indexed keywords

FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; MALE; PLATELET MICROPARTICLE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; RISK REDUCTION; SLEEP APNEA SYNDROME; THROMBOCYTE ACTIVATION;

BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; FIBRIN; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET ACTIVATION; POLYSOMNOGRAPHY; PROGNOSIS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84856613119     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.8565     Document Type: Article

References (20)

1. Peker Y, Hedner J, Kraiczi H, Loth S: Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med, 2000; 162: 81-86
2. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U: Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med, 2001; 164: 1910-1913
3. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR: Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax, 2004; 59: 777-782
4. Von Kanel R, Loredo JS, Ancoli-israel S, Dimsdale JE: Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath, 2006; 10: 139-146
5. Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M: In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration, 2002; 69: 229-234
6. Hui DS, Ko FW, Fok JP, Chan MC, Li TS, Tomlinson B, Cheng G: The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest, 2004; 125: 1768-1775
7. McNicholas WT: Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome. Am J Physiol Regul Integr Comp Physiol, 2007; 293: 1666-1670
8. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Oda N, Tanaka A, Yamamoto M, Ohta S, O'Donnell CP, Adachi M: Silent brain infaction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med, 2007; 175: 612-617
9. Mackman N: On the trail of microparticles. Circ Res, 2009; 104: 925-927
10. Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, Komiyama Y, Fujimura Y, Ikeda Y, Fukuhara S: High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood, 1996; 88: 3456-3464
11. Holme PA, Orvim U, Hamers MJAG, Solum NO, Brosstad FR, Barstad RM, Sakariassen KS: Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol, 1997; 17: 646-653
12. Nomura S: Function and clinical significance of plateletderived microparticles. Int J Hematol, 2001; 74: 397-404
13. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI: Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Heamost, 2007; 97: 425-434
14. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ: Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem, 1991; 266: 17261-17268
15. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ: Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem, 1988; 263: 18205-18212
16. Nomura S, Shouzu A, Taomoto K, Togane Y, Goto S, Ozaki Y, Uchiyama S, Ikeda Y: Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. J Atheroscler Thromb, 2009; 16: 878-887
17. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A: Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost, 2001; 85: 810-820
18. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R: Microparticles in cardiovascular diseases. Cardiovasc Res, 2003; 59: 277-287
19. Siegal T, Seligsohn V, Aghai E, Modan M: Clinical and laboratory aspects of disseminated intravascular coagulation (DIC). Thromb Haemost, 1978; 39: 122-134
20. Gozal D, Kheirandish-Gozal L: Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med, 2008; 177: 369-375